--Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the presentation of updated long-term safety and efficacy data from a ...
The CIRCULATE Spain study: Circulating tumor DNA based decision for adjuvant treatment in localized colon cancer. PACE: A phase III trial of CAPOX versus anti-PD-1 inhibitor as adjuvant therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results